Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC.
Recalled January 14, 2026 · FDA recall D-0251-2026 · Imprimis NJOF
Hazard
Presence of particulate matter - Glass like particles. · FDA Class II
Units
314 boxes of 6,280 pre-filled syringes
Sold at
U.S Nationwide
Description
Presence of particulate matter - Glass like particles.
Product
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →